Article Text
Statistics from Altmetric.com
Patrick Radden Keefe is an investigative journalist with a reputation for exposing the bad guys, particularly those who are adept at laundering their reputations. This book chronicles the life of the Sackler family, particularly the eldest brother Arthur who was clearly very talented and entrepreneurial from a young age. Thank (or blame) him for any drug lunches you have enjoyed—remembered fondly as a weekly treat by the more senior in our group—as visits from the progenitors of ‘drug reps’ became the accepted way for the dynasty to increase their sales.
The focus of the book is OxyContin, a drug which some believe is responsible for two hundred thousand deaths. One colleague pointed out that their original goal was to develop OxyContin as a pain killer for patients with intractable cancer-related pain at a time when palliative care services were not well developed; they found it hard to believe that the Sacklers could have foreseen how their endeavours would be …
Footnotes
Contributors A-WM collected notes during the book club and wrote the article’s first draft. TATH edited and rewrote parts of the article.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; internally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Legislative, educational, policy and other interventions targeting physicians’ interaction with pharmaceutical companies: a systematic review
- Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians’ attitudes and prescribing habits: a systematic review
- Interactions of doctors with the pharmaceutical industry
- Barriers to patient enrolment in phase III cancer clinical trials: interviews with clinicians and pharmaceutical industry representatives
- Medical students’ exposure to and attitudes towards product promotion and incentives from the pharmaceutical industry in 2019: a national cross-sectional study in France
- Prescription preferences in antipsychotics and attitude towards the pharmaceutical industry in Belgium
- Perceptions of the provision of drug information, pharmaceutical detailing and engagement with non-personal promotion at a large physicians network: a mixed-methods study
- Failure to discount for conflict of interest when evaluating medical literature: a randomised trial of physicians
- Questionable content of an industry-supported medical school lecture series: a case study
- General practitioners and pharmaceutical sales representatives: quality improvement research